Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report

about

Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension.Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients.

P2860

Q41879602-2B52162E-2572-425F-899E-D4B9C51E71FC Q47346411-80F0183F-378D-43AE-8B0C-5FD785375361

P2860

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report

Item

http://www.wikidata.org/entity/Q36299271

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@ast

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@en

type

Item

label

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@ast

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@en

prefLabel

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@ast

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@en

P1476

Bevacizumab to Treat Cholangio ...... ia: Be Cautious: A Case Report

@en

P2093

Amélie Servettaz

http://www.w3.org/2001/XMLSchema#string

Quentin Maestraggi

http://www.w3.org/2001/XMLSchema#string

Reza Kianmanesh

http://www.w3.org/2001/XMLSchema#string

Roland Jaussaud

http://www.w3.org/2001/XMLSchema#string

Ségolène Toquet

http://www.w3.org/2001/XMLSchema#string

P2860

ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.

Ischemic cholangiopathy.

Liver involvement in hereditary hemorrhagic telangiectasia (HHT).

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.

Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab.

P304

e1966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001966

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francois Durand

Mohamed Bouattour

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26579805

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

hereditary hemorrhagic telangiectasia

P932

4652814

http://www.w3.org/2001/XMLSchema#string

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report

about

P2860

P2860

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932